Evidence map›Paper›PMID 34240055›Full record

ArticleJAC-antimicrobial resistance2020

Prolonged empirical antibiotic therapy is correlated with bloodstream infections and increased mortality in a tertiary care hospital in Ethiopia: bacteriology testing matters.

Makeda Semret, Workeabeba Abebe, Ling Yuan Kong, Tinsae Alemayehu, Temesgen Beyene, Michael D Libman, Wondwossen Amogne, Øystein Haarklau Johannsen, Gebremedhin B Gebretekle, Daniel Seifu and 1 more

Open access · goldAbstract read
In one paragraph

Article in JAC-antimicrobial resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Canadian Antibiotic Prescribing for Sepsis (CAPS) Study: AJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. The neglected importance of high-endemic ESBL sites.JAC-antimicrobial resistance · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2021
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Makeda SemretDepartment of Medicine and JD MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada.ORCID 0000-0003-3875-4847
Workeabeba AbebeSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Ling Yuan KongDepartment of Medicine and JD MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
Tinsae AlemayehuSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Temesgen BeyeneSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Michael D LibmanDepartment of Medicine and JD MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
Wondwossen AmogneSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Øystein Haarklau JohannsenVestfold Hospital Trust and Department of Clinical Science, University of Bergen, Tønsberg, Norway.
Gebremedhin B GebretekleSchool of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Daniel SeifuSchool of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Cedric P YansouniDepartment of Medicine and JD MacLean Centre for Tropical Diseases, McGill University Health Centre, Montreal, Quebec, Canada.
Addis Ababa University · ETMcGill University Health Centre · CASykehuset i Vestfold · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHospital-associated infection (HAI) and antimicrobial resistance (AMR) are major health threats in low- and middle-income countries (LMICs). Because diagnostic capacity is lacking throughout most of Africa, patients are commonly managed with prolonged empirical antibiotic therapy. Our goal was to assess mortality in relation to HAI and empirical therapy in Ethiopia's largest referral hospital.

methodsCohort study of patients with suspected HAI at Tikur Anbessa Specialized Hospital from October 2016 to October 2018. Blood culture testing was performed on an automated platform. Primary outcomes were proportion of patients with bloodstream infection (BSI), antibiotic resistance patterns and 14 day mortality. We also assessed days of therapy (DOT) pre- and post-blood culture testing.

resultsOf 978 enrolled patients, 777 had blood culture testing; 237 (30%) had a BSI. Enterobacteriaceae were isolated in 49%; 81% of these were cephalosporin resistant and 23% were also carbapenem resistant. Mortality at 14 days was 31% and 21% in those with and without BSI, respectively. Ceftriaxone resistance was strongly correlated with mortality. Patients with BSI had longer DOT pre-blood culture testing compared with those without BSI (median DOT 12 versus 3 days, respectively,

conclusionsBSI are frequent and fatal among patients with suspected HAI in Ethiopia. Highly resistant blood isolates are alarmingly common. This study provides evidence that investing in systematic blood culture testing in LMICs identifies patients at highest risk of death and that empirical management is frequently inappropriate. Major investments in laboratory development are critical to achieve better outcomes.

Identifiers

PMID34240055
PMCPMC8210023
OpenAlexW3042109114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.